CONNAUGHTON BERNADETTE sold 4.7% of their position (2K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $140.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/6/2026ACC: 0001159036-26-000006
Director
Since Sep 2018
-2K
Net shares
Net seller
$140.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
$70.25
Trade value
$140.50K
% of position
4.7%
1/5/2026
42.12K→40.12K
Total
Net shares
−2K
Net value
-$140.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | S · Sale | −2K | $70.25 | $140.50K | 4.7% | 42.12K | 40.12K |
| Total | −2K | -$140.50K | ||||||
Derivative Transactions0
No derivative transactions reported